Citadel Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-200
Closed -$5.7K 14739
2025
Q1
$5.7K Hold
200
﹤0.01% 13800
2024
Q4
$6.61K Buy
+200
New +$7.55K ﹤0.01% 13787
2024
Q2
Sell
-2,000
Closed -$71.5K 15249
2024
Q1
$71.5K Sell
2,000
-2,000
-50% -$69.3K ﹤0.01% 11792
2023
Q4
$132K Hold
4,000
﹤0.01% 10585
2023
Q3
$109K Buy
4,000
+2,800
+233% +$84.3K ﹤0.01% 10783
2023
Q2
$37.9K Sell
1,200
-800
-40% -$24.8K ﹤0.01% 12115
2023
Q1
$54.4K Sell
2,000
-400
-17% -$12.1K ﹤0.01% 12048
2022
Q4
$72.9K Buy
+2,400
New +$72.2K ﹤0.01% 11651
2021
Q1
Sell
-6,300
Closed -$323K 13655
2020
Q4
$323K Buy
+6,300
New +$300K ﹤0.01% 8944
2019
Q2
Sell
-7,900
Closed -$286K 9759
2019
Q1
$286K Buy
+7,900
New +$264K ﹤0.01% 7689
2018
Q4
Sell
-5,300
Closed -$209K 9669
2018
Q3
$209K Buy
+5,300
New +$201K ﹤0.01% 8151

Other funds holding SBIO